Dermata Therapeutics
Stock Forecast, Prediction & Price Target

Dermata Therapeutics Financial Estimates

Dermata Therapeutics Revenue Estimates

Dermata Therapeutics EBITDA Estimates

Dermata Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $15M
Low: $15M
High: $15M
avg. 0%
Net Income
 
% change YoY
$-7.94M
 
N/A
$-9.61M
 
-20.92%
$-7.79M
 
18.89%
Avg: $-15.58M
Low: $-898.76K
High: $-898.76K
avg. -99.93%
Avg: $-16.06M
Low: $-664.81K
High: $-664.81K
avg. -3.06%
EBITDA
 
% change YoY
$-7.85M
 
N/A
$-9.67M
 
-23.13%
$247.21K
 
102.55%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$15.27
 
N/A
-$13.92
 
8.84%
-$40.18
 
-188.64%
Avg: -$4.61
Low: -$4.61
High: -$4.61
avg. 88.52%
Avg: -$3.41
Low: -$3.41
High: -$3.41
avg. 26.03%
Operating Expenses
 
% change YoY
$7.85M
 
N/A
$9.67M
 
23.13%
$8.04M
 
-16.87%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Dermata Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -51.49% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -898.76K, average is -15.58M and high is -898.76K.

What is Dermata Therapeutics stock revenue growth forecast?

We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Dermata Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 57.27% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$4.61, average is -$4.61 and high is $-4.61.